# Efficacy and Safety Study of GerEPO

> **NCT00229099** · PHASE3 · COMPLETED · sponsor: **Ministry of Health, Malaysia** · enrollment: 270 (—)

## Conditions studied

- Chronic Renal Failure Related Anemia

## Interventions

- **DRUG:** GerEPO

## Key facts

- **NCT ID:** NCT00229099
- **Lead sponsor:** Ministry of Health, Malaysia
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 270 (—)
- **Last updated:** 2006-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00229099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00229099, "Efficacy and Safety Study of GerEPO". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00229099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*